The symptoms of multiple sclerosis (MS) can differ from person ... There are four typical patterns of progression of the disease. This is the early pattern, where the first episode of neurologic ...

Perhaps the most convincing evidence that myelin-reactive T cells lead to inflammatory demyelination came from a clinical trial ... at the edge of the chronic multiple sclerosis lesion.

UC San Francisco scientists have successfully completed a Phase II clinical trial showing that an FDA-approved antihistamine restores nervous system function in patients with chronic multiple ...

Relapsing-remitting multiple sclerosis is a type of multiple sclerosis ... During remission, new symptoms typically resolve or improve. MS is a chronic, progressive condition of the central ...

In addition, iron-rich phagocytes were consistently found at the edge of chronic demyelinated lesions. These outcomes suggest that MRI-based clinical trials focused on treating perilesional ...

2 As Bionews reported, prior research has not argued for a particular diet regimen in patients with multiple sclerosis ... patterns, rather than on single foods/nutrients, in chronic disease ...

The researchers, representing leading universities and hospitals in Europe and USA, will perform clinical trials ... and co-responsibility Multiple sclerosis (MS) is a chronic inflammatory and ...

Current disease-modifying therapies for multiple sclerosis have limited effects on disability accrual unrelated to relapses, which is thought to be partially caused by chronic, nonresolving ...